No Data
No Data
Nutex Health Is Maintained at Buy by Benchmark
Nutex Health Analyst Ratings
Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Cuts Target Price to $45
Earnings Call Summary | Nutex Health(NUTX.US) Q2 2024 Earnings Conference
Nutex Health (NUTX) Q2 2024 Earnings Call Transcript
Express News | Nutex Health Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
No Data